Discontinuering

Discontinuering is the process of ending the production, sale, or continued support of a product, service, or activity. The term is commonly used in Dutch-language contexts to refer to phasing out or withdrawing something from the market or from use. In English, the equivalent term is discontinuation or phase-out.

In medicine and pharmacology, discontinuering refers to stopping a medication or therapy, often guided by clinical recommendations, patient safety, and tapering schedules. In business and technology, it describes the retirement of a product line, service, software version, or hardware model. In regulatory settings, authorities may require discontinuation due to safety, efficacy, or compliance concerns.

Reasons for discontinuering include safety concerns, dwindling demand, supply shortages, cost of maintenance, strategic refocusing, or obsolescence of technology. The decision is typically accompanied by a formal assessment, stakeholder consultation, and a transition plan to minimize disruptions for users and customers.

Typical steps involve announcing the discontinuation, setting a sunset date for sales, providing alternatives or replacement products, offering support for existing users for a defined period, and ensuring data or patient records are handled according to privacy and legal requirements.

Discontinuering can affect patients, consumers, employees, and partners. Proper communication, clear timelines, and reasonable transition assistance help mitigate negative impacts. Related concepts include phase-out, withdrawal, retirement, sunset provisions, and product lifecycle management.